Core Laboratories (CLB) Stock Price

Core Laboratories Price

NYSE·CLOSED
10.11
​
Market closed

Revenue at Core Laboratories has contracted by 0.5% per year over the past 19 years to 526.52 M USD. Earnings per share have declined at 4.8% per year over the last 19 years. Core Laboratories's net margin stands at 5.6%, up from 4.2% several years earlier. Core Laboratories currently offers a dividend yield of about 0.40%. The payout ratio is around 6% of earnings. Analysts set a median price target of 21.00 USD, implying 107.7% above the current price. Of 10 analysts, 1 rate the stock a buy — an overall Sell consensus.

Core Laboratories stock price

Access this data via the Eulerpool API

Core Laboratories business model & stock analysis

Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. The company is headquartered in Amsterdam, Noord-Holland and currently employs 4,300 full-time employees. The firm operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. The company provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. The company provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Frequently asked questions about Core Laboratories

Analysts currently set an average price target of 21.00 USD for the Core Laboratories stock (median: 21.00 USD), implying +107.7 % versus the latest price. The consensus is based on 10 analyst ratings.

10 analysts currently rate the Core Laboratories stock: 1 recommend buying, 3 holding and 6 selling. For 2026, analysts expect Core Laboratories to generate revenue of 510.89 M USD and earnings per share of 0.49 USD.

Converted at the current exchange rate, the Core Laboratories share trades at 9.03 EUR (10.11 USD).

The Core Laboratories share (CLB) is listed on 6 stock exchanges, including: NYSE (CLB), London (0Q82.L), SIX (Zürich) (CEI.SW), Frankfurt (CEI.F), Düsseldorf (CEI.DU), Amsterdam (CLB.AS).

The expected revenue of Core Laboratories is 510.89 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Core Laboratories is 22.61 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Core Laboratories is currently 20.79. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Core Laboratories stock.

The price-to-sales ratio (P/S) of Core Laboratories is currently 0.92. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Core Laboratories stock.

The Eulerpool Quality Score for Core Laboratories is 3/10.

The ISIN of Core Laboratories is US21867A1051. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Core Laboratories is 897269. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Core Laboratories is CLB. The ticker symbol is used to trade Core Laboratories shares on the stock exchange.

Fair ValueTerminal
9.50 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Energy Equipment & Services
Number of shares
Employees
Revenue per Employee
159,551.52 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website corelab.com
Country
Netherlands
Currency
USD
Initial public offering
Jul 10, 1998
ISIN
US21867A1051
Cusip
N22717107
Sedol
2182531
Market capitalization
475.45 M USDSmall Cap
52-Week Range
PEG
0.61
P/E ratio
P/Ee 2026
21.03
P/Ee 2027
13.94
P/Ee 2028
10.47
P/S
P/Se
0.92
EV/EBIT
10.70
P/B Ratio
1.79
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
7.89 %
Dividend
Dividend yield
0.40 %
Est. Dividend Yield
0.40 %
Payout Ratio
6.27 %
Dividend growth Ø5Y
—
Dividend payments per year
4
Dividend paid since
18 years
Dividend not reduced since
4 years
Dividend increased since
0 years
Dividend withholding tax
15.00 %
Last updated Oct 8, 2026, 5:00 PM

Core Laboratories Peer Group

Core Laboratories Ticker

AMSTERDAM · CLB.ASDÜSSELDORF · CEI.DUFRANKFURT · CEI.FLONDON · 0Q82.LNEW YORK · CLBSIX · CEI.SW